MAPT and Alzheimer disease: During the pathological process of AD, GSK3β induces tau phosphorylation on a set of phosphorylated residues, leading to tau separation from microtubules, destabilizing the cytoskeleton, and forming neurotoxic oligomers, further impairing cell function.